 | ||||||||||||
|
News
Carcinoma
| Aveo suffers new setback on kidney cancer drug The drug treats renal cell carcinoma, a type of kidney cancer that kills tens of thousands of people worldwide every year. While the Food and Drug Administration is expected to rule by July 28 whether to approve Aveo's capsule for sale in the United ... Boston Globe - Fri, 24 May 2013 14:03 | |
| Aveo slumps as Astellas pares cancer drug support Businessweek - Fri, 24 May 2013 07:46 | |
| AVEO Pharmaceuticals (AVEO) has been informed by its partner, Astellas ... Seeking Alpha - Thu, 23 May 2013 15:22 | |
| Aveo partner will not seek European approval for kidney cancer drug Boston Business Journal (blog) - Fri, 24 May 2013 13:41 | |
| Pazopanib for Metastatic Renal Cell Carcinoma? Possibly…. An international clinical trial re-ported that overall survival (OS) was not significantly different for patients with metastatic renal cell carcinoma (RCC) treated with pazopanib versus placebo. However, further analysis suggested that there may ... Clinical Oncology News - Thu, 23 May 2013 10:25 | |
 | Nonmelanoma can dangerous, disfiguring and deadly May is Skin Cancer Awareness Month, and while the dangers of melanoma are well known, it is important not to neglect the warning signs of the two most common types of skin cancer: basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), which ... Columbus Telegram - Fri, 24 May 2013 07:15 |
| May is National Melanoma Awareness Month Patch.com - Mon, 20 May 2013 11:36 | |
| Dermatologists urge people to learn the ABCDEs of skin cancer The Columbian - Mon, 20 May 2013 06:14 | |
| Skin cancer: Prevention and early detection are keys to recovery County 10 - Wed, 22 May 2013 11:56 | |
| Health Checkup: Preventing skin cancer takes more than sunscreen Rochester Democrat and Chronicle - Wed, 22 May 2013 02:04 | |
| Cell therapy to fight skin cancer HealthCanal.com - Fri, 24 May 2013 02:22 | |
| Basal-cell carcinoma targeted by new deoxyribozyme drug Basal-cell carcinoma targeted by new deoxyribozyme drug. A new class of drugs targeting the genetic material of skin cancer has been successfully tested in humans for the first time. This opens the way to new treatments for a range of conditions from ... Oncology Nurse Advisor - Wed, 22 May 2013 05:41 | |
| Bayer begins phase III trial of regorafenib in patients with hepatocellular ... Bayer HealthCare, a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials, has started to enroll patients in an international phase III trial to evaluate the efficacy and safety of regorafenib for ... pharmabiz.com - Wed, 15 May 2013 22:42 | |
| Bayer HealthCare commences phase III liver cancer drug trial Zenopa - Wed, 15 May 2013 03:02 | |
 | HIV Is No Barrier To Successful Liver Transplant For Cancer Treatment As people infected with HIV live longer with antiretroviral drug therapy, more of them are developing hepatocellular carcinoma (HCC), which is particularly aggressive among this population. HCC, also called malignant hepatoma, is the most common type ... Medical Daily - Sat, 18 May 2013 14:30 |
| Researchers close to non-surgical skin cancer treatment The two main types are basal cell carcinoma and squamous cell carcinoma. Scientists at the University of Queensland are testing a new treatment, which takes cells from the body and manipulates them so they are rich in anti-tumour properties. They are ... ABC Online - Tue, 21 May 2013 00:38 | |
| HERA Trial: Invasive Lobular Breast Carcinoma Patients Derived Same Benefit ... Patients with invasive lobular breast cancer who participated in the HERA (Herceptin Adjuvant) trial derived similar benefits from 1 year of trastuzumab(Drug information on trastuzumab) maintenance therapy as those patients with invasive ductal carcinoma. Cancer Network - Tue, 07 May 2013 08:19 | |